Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 469Erstellt: 23. Oktober 2026

Benzenesulfonamide, 4-amino-N-[2-(4-morpholinyl)ethyl]- → 4-[4-(2,6-Dimethylpyridin-3-yloxy)pyridin-2-ylamino]-N-(2-morpholinoethyl)benzenesulfonamide

https://huagongshe.com/de/reaction/469

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
EduktBenzenesulfonamide, 4-amino-N-[2-(4-morpholinyl)ethyl]-HCID 120569—
Edukt3-(2-Chloropyridin-4-yl)oxy-2,6-dimethyl-pyridineHCID 44598200—
ReagenzCesium carbonateHCID 10796—
Katalysator1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
KatalysatorPalladium (II) acetateHCID 4144353—
LösungsmittelDimethylacetamideHCID 31374—
Produkt4-[4-(2,6-Dimethylpyridin-3-yloxy)pyridin-2-ylamino]-N-(2-morpholinoethyl)benzenesulfonamideHCID 6894667760,66%

Reaktionsbedingungen

Temperatur150 °C

Reaktionsschritte

In a 10 mL microwave reactor 3-(2-chloropyridin-4-yloxy)-2,6-dimethylpyridine (100 mg, 0.43 mmol) and 4-amino-N-(2-morpholinoethyl)benzenesulfonamide (122 mg, 0.43 mmol) were dissolved in DMA (5 mL) to give a tan solution.To the resultant solution Cesium carbonate (0.068 mL, 0.85 mmol) was added and sparged with nitrogen for 1 minute. Then Palladium(II) acetate (6.70 mg, 0.03 mmol) and 9,9-Dimethyl-4,5-bis(diphenylphosphino)xanthene (29.6 mg, 0.05 mmol) were added and the reaction mixture was sealed. The reaction was heated to150 °C for 25 minutes in the biotage microwave.The reaction was cooled to room temperature and LCMS shows reaction was completed. Reaction mixture was filtered through Celite Bed and washed with Dichloromethane. Filtrate was subjected to concentration to get DMA solution which was given to analytical department to purify using Mass based HPLC. After purification compound was isolated to get pale yellow solid of 4-(4-(2,6-dimethylpyridin-3-yloxy)pyridin-2-ylamino)-N-(2-morpholinoethyl)benzenesulfonamide (125 mg, 60.7 %)

Herkunft & Nachweise

Quelldatensatz750 AstraZeneca ELN dataset
ORD IDord-7897aa67f78748769844b414acdceeae
Quellennotiz750 AstraZeneca ELN dataset